Skip to main content
OpenTrials

Clinical trial condition

Refractory Plasma Cell Myeloma

Explore clinical trials studying Refractory Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.

55 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Refractory Plasma Cell Myeloma trial results

Recruiting

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT04508790

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Seacliff Huntington Beach, California, United States
  • City of Hope at Antelope Valley Lancaster, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
View Trial Details
Completed

Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement

NCT02765854

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Grady Memorial Hospital Atlanta, Georgia, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Michigan/Rogel Cancer Center Ann Arbor, Michigan, United States
  • Washington University/Siteman Cancer Center St Louis, Missouri, United States
View Trial Details

Related conditions